Why Novo Nordisk's Surprise Win Hammered Agios Pharmaceuticals StockInvestors Business Daily • 04/20/26
Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ETGlobeNewsWire • 04/06/26
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCDZacks Investment Research • 04/01/26
Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? You May Have Been Affected by Fraud- Contact Levi & KorsinskyPRNewsWire • 04/01/26
Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?Zacks Investment Research • 04/01/26
Agios Pharma Rallies On A Surprise FDA Move In Sickle Cell DiseaseInvestors Business Daily • 03/31/26
AGIO ALERT- The Gross Law Firm Has Commenced an Investigation on Behalf of Agios Pharmaceuticals, Inc. Shareholders Who Lost MoneyPRNewsWire • 03/31/26
PK Activation Gains Momentum in Thalassemia Agios' Aqvesme Launch Reflects Strong Promise with Deliberate UptakeGlobeNewsWire • 03/31/26
Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDAGlobeNewsWire • 03/31/26
AGIO STOCK ALERT: Levi & Korsinsky Notifies Agios Pharmaceuticals, Inc. Investors of an Ongoing InvestigationPRNewsWire • 03/25/26
ATTENTION AGIO SHAREHOLDERS: Investors who lost money on Agios Pharmaceuticals, Inc. are urged to contact Levi & Korsinsky about an ongoing investigationPRNewsWire • 03/18/26
Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? Contact The Gross Law Firm Regarding an Ongoing InvestigationPRNewsWire • 03/17/26
Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? Contact Levi & Korsinsky Regarding an Ongoing InvestigationPRNewsWire • 03/11/26
Agios Pharmaceuticals, Inc. Investigated Regarding Potential Securities Law Violations - Contact The Gross Law Firm for Details- AGIOPRNewsWire • 03/10/26
Levi & Korsinsky Reminds Agios Pharmaceuticals, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - AGIOPRNewsWire • 03/04/26
Agios Pharmaceuticals, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact The Gross Law Firm Regarding Potential Securities Law Violations - AGIOPRNewsWire • 03/03/26
Agios' PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in the United Arab EmiratesGlobeNewsWire • 03/02/26
From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million BackerThe Motley Fool • 02/23/26
Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November CrashThe Motley Fool • 02/17/26